跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Analog II
首页
药物
Analog II
Analog II
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITION FOR THE MANAGEMENT OF NAUSEA AND VOMITING
EP 3024466 B1
申请人: DUCHESNAY INC
优先权: 2013
CN
EP
US
WO
9 件公开
FORMULATIONS FOR ADMINISTRATION OF EFLORNITHINE
EP 3523274 B1
申请人: ORBUS THERAPEUTICS INC
优先权: 2016
CN
EP
US
WO
9 件公开
Lipidic furan, pyrrole, and thiophene compounds for treatment of cancer, neurological disorders, and fibrotic disorders
CN 105209037 A
申请人: AVOSCIENCE LLC
优先权: 2013
CN
US
9 件公开
Means and methods for preventing and/or treating caries
EP 1634948 A1
申请人: BASF AG
优先权: 2004
CN
EP
US
7 件公开
Oligonucleotide analog and method for treating flavivirus infections
US 2005096291 A1
申请人: IVERSEN PATRICK L
优先权: 2004
CN
US
7 件公开
Contrast agents
US 6921525 B2
申请人: AMERSHAM HEALTH AS
优先权: 2001
US
6 件公开
Dual-agonist compound for both GLP-1 and GIP receptors and application thereof
US 12653865 B2
申请人: JIANGSU HENGRUI PHARMACEUTICALS CO LTD
优先权: 2020
CN
EP
US
WO
5 件公开
Buprenorphine analogs
EP 2703404 A1
申请人: PURDUE PHARMA LP
优先权: 2008
CN
EP
US
4 件公开
US 9175000 B2
申请人: PURDUE PHARMA LP
优先权: 2013
US
2 件公开
ENHANCED OSTEOGENIC ACTIVITY OF DAIDZEIN ANALOGS ON HUMAN MESENCHYMAL STEM CELLS
EP 2981530 B1
申请人: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
优先权: 2013
EP
US
WO
4 件公开
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
US 11084800 B2
申请人: ACHILLION PHARMACEUTICALS INC
优先权: 2017
CN
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈